Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma

This study has been completed.
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: January 23, 2013
Last updated: September 20, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2016
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)